About Brent Saunders
Form D filings for GLO Pharma in 2023 list Brent Saunders as director.
Brent Saunders first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brent Saunders in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brent Saunders works with at each company, as listed on that company's latest Form D.
GLO Pharma, Inc. · Form D/A, Apr 3, 2023
MB
Marla Beck
Director
NQ
Nicole Quinn
Director
DQ
Dayna Quanbeck
Director
SG
Scott Glenn
Director
VG
Vimla Black-Gupta
President and Chief Executive Officer, director
LO
Lauren Otsuki
Executive officer and director